ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,835Medicare Part D Prescriptions Filled, Including Refills

Rank: 329 out of 972

$558K Total Retail Price of All Prescriptions

Rank: 262 out of 972

266 Patients Receiving at Least One Drug in Part D
45%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 266 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

26% of this provider’s 266 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

0% of this provider’s 2,812 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
HYDROCODONE-ACETAMINOPHEN 372 132 S3 1 6
LISINOPRIL 353 112 2 1
FUROSEMIDE 284 99 3 7
SIMVASTATIN 255 63 4 2
OMEPRAZOLE 254 112 5 5
RANITIDINE HCL 193 37 6 24
METFORMIN HCL 181 48 7 8
PROAIR HFA 166 30 8 47
GABAPENTIN 164 34 9 14
LEVOTHYROXINE SODIUM 148 84 10 3
WARFARIN SODIUM 148 66 10 12
POTASSIUM CHLORIDE 136 54 12 13
SPIRIVA 135 27 13 56
CARVEDILOL 134 57 14 21
ADVAIR DISKUS 126 20 15 45
CITALOPRAM HBR 126 53 15 19
NEXIUM 118 12 17 30
AZITHROMYCIN 115 32 18 42
TRAMADOL HCL 113 31 19 15
PREDNISONE 113 39 19 40
FLUTICASONE PROPIONATE 92 33 21 31
ATORVASTATIN CALCIUM 91 31 22 11
TRAZODONE HCL 91 21 22 35
AMLODIPINE BESYLATE 83 25 24 4
CELEBREX 82 15 25 85
METOPROLOL TARTRATE 80 37 26 9
AMITRIPTYLINE HCL 79 0 R 27 58
METOPROLOL SUCCINATE 78 16 28 16
OXYCODONE HCL-ACETAMINOPHEN 78 12 S2 28 106
CYCLOBENZAPRINE HCL 77 0 R 30 53
ZOLPIDEM TARTRATE 71 32 31 23
MELOXICAM 70 22 32 36
JANUVIA 70 13 32 75
SPIRONOLACTONE 69 33 34 54
ISOSORBIDE MONONITRATE ER 68 20 35 43
SINGULAIR 65 11 36 81
HYDROCHLOROTHIAZIDE 62 13 37 10
BACLOFEN 61 19 38 123
CARISOPRODOL 58 0 R 39 110
LOVASTATIN 57 39 40 22
GLIPIZIDE 57 34 40 59
OXYCONTIN 57 0 S2 40 139
NAPROXEN 57 13 40 71
LYRICA 56 0 44 113
CLOPIDOGREL 54 33 45 37
DALIRESP 53 17 46 307
OXYBUTYNIN CHLORIDE 52 12 47 97
TRICOR 50 0 48 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.